tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Donald Ellis, 32 are a BUY (94.12%), 2 are a HOLD (5.88%).
Analyst Donald Ellis, currently employed carries an average stock price target met ratio of 50.63% that have a potential upside of 80.73% achieved within 360 days. Previously, Donald Ellis worked at JMP.
Donald Ellis’s has documented 67 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CLSD, Clearside Biomedical at 21-Dec-2021.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for CLSD (CLEARSIDE BIOMEDICAL) at 10/24/2019. The price target of $4 was fulfilled within 448 days with a profit of $3.08 (334.78%) receiving and performance score of 7.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$8
$5.28 (194.12%)
1 months 2 days ago
(19-Nov-2024)
0/3 (0%)
$3.83 (91.85%)
Hold
$7
$4.28 (157.35%)
1 months 2 days ago
(19-Nov-2024)
1/5 (20%)
$2.83 (67.87%)
315
Hold
$13
$10.28 (377.94%)
$2
1 months 3 days ago
(18-Nov-2024)
1/5 (20%)
$10.46 (411.81%)
354
Hold
3 months 4 days ago
(17-Sep-2024)
0/5 (0%)
$34.34 (396.54%)
Hold
$1
$-1.72 (-63.24%)
$2
1 years 3 days ago
(18-Dec-2023)
2/4 (50%)
$0.06 (6.38%)
178
What Year was the first public recommendation made by Donald Ellis?
